<DOC>
	<DOCNO>NCT00517673</DOCNO>
	<brief_summary>GSK945237 first molecule new chemical class develop treatment respiratory tract infection skin soft tissue . This study drug test animal never give human . This two part study . The purpose first part study side effect drug human , study much drug get absorb blood stream The second part study compare absorption study drug blood stream give food give fasting condition</brief_summary>
	<brief_title>To Evaluate Safety , Tolerability , Pharmacokinetics , And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>Healthy male female adult 18 60 year age . Body weight proportional height . Female subject must nonchildbearing potential . QTc le 450 msec screen Any clinically relevant abnormality identify screen history physical , laboratory evaluation 12lead surface electrocardiogram screen predose . A positive prestudy alcohol/urine drug screen . Use nicotinecontaining product . A positive prestudy HIV antibody , Hepatitis B surface antigen ( HBsAg ) Hepatitis C antibody result . Recent participation another study , use certain medication , consumption certain fruit , juice , red wine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Healthy Volunteer</keyword>
</DOC>